Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey

Clinical Microbiology and Infection

Volumn 14, Issue 4, 2008, Pages 388-390

  Cevik, M ^a   Beyazova, U ^a   Aral, A L ^a   Duyan Camurdan, A ^a,b   Ozkan, S ^a   Sahin, F ^a   Aybay, C ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Antibodies; Bordetella pertussis; ELISA; Immunity; Seroprevalence; Vaccination recommendations

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; AGE; ANTIBODY TITER; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNITY; MALE; NORMAL HUMAN; PERTUSSIS; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; TURKEY (REPUBLIC);

BORDETELLA PERTUSSIS;

EID: 40549126957     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01926.x     Document Type: Article

References (10)

1. Cherry JD Immunity to pertussis Clin Infect Dis 44 2007 1278 1279
2. Van der Wielen M Van Damme P Van Herck K Schlegel-Haueter S Siegrist CA Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium) Vaccine 21 2003 2412 2417
3. Cagney M MacIntyre CR McIntyre P Puech M Giammanco A The seroepidemiology of pertussis in Australia during an epidemic period Epidemiol Infect 134 2006 1208 1216
4. Cattaneo LA Reed GW Haase DH Wills MJ Edwards KM The seroepidemiology of Bordetella pertussis infections: a study of persons aged 1–65 years J Infect Dis 173 1996 1256 1259
5. Jenkinson D Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study BMJ 296 1988 612 614
6. Dominguez A Vidal J Plans P Salleras L The seroepidemiology of B. pertussis infection in Catalonia, Spain Epidemiol Infect 126 2001 205 210
7. Wirsing von Konig CH Campins-Marti M Finn A Guiso N Mertsola J Liese J Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations Pediatr Infect Dis J 24 suppl 5 2005 87 92
8. Tan T Halperin S Cherry JD Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations Pediatr Infect Dis J 24 suppl 5 2005 83 86
9. Torvaldsen S McIntyre PB Effect of the preschool pertussis booster on national notifications of disease in Australia Pediatr Infect Dis J 22 2003 956 959
10. Cherry JD Grimprel E Guiso N Heininger U Mertsola J Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives Pediatr Infect Dis J 24 suppl 5 2005 25 34